WHO-UMC IDMP Management and Publish API
0.1.0 - CI Build International flag

WHO-UMC IDMP Management and Publish API, published by Uppsala Monitoring Centre. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Uppsala-Monitoring-Centre/WHO-UMC-IDMP-Service/ and changes regularly. See the Directory of published versions

: Task example from DataPharm (UK) - XML Representation

Raw xml | Download


<Task xmlns="http://hl7.org/fhir">
  <id value="UK-emc-00001"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Task UK-emc-00001</b></p><a name="UK-emc-00001"> </a><a name="hcUK-emc-00001"> </a><a name="UK-emc-00001-en-US"> </a><p><b>status</b>: Draft</p><p><b>intent</b>: proposal</p><p><b>priority</b>: Routine</p><p><b>authoredOn</b>: 2024-01-17</p><p><b>lastModified</b>: 2024-01-17</p><blockquote><p><b>input</b></p><p><b>type</b>: <span title="Codes:{http://who-umc.org/idmp/CodeSystem/task-input-type mpd-request-resource}">Medicinal Product for PhPID request</span></p><p><b>value</b>: <a href="#hcUK-emc-00001/5d02cfc1-053f-4694-9ce8-d0ee6c658b72">MedicinalProductDefinition: identifier = http://medicines.org.uk/product#511; type = Medicinal Product; domain = Human use; status = Active; statusDate = 2020-08-03 15:11:41+0000; combinedPharmaceuticalDoseForm = Tablet and powder for oral solution; classification = methotrexate</a></p></blockquote><blockquote><p><b>input</b></p><p><b>type</b>: <span title="Codes:{http://who-umc.org/idmp/CodeSystem/task-input-type ingredient-request-resource}">Ingredient for PhPID request</span></p><p><b>value</b>: <a href="#hcUK-emc-00001/54c6c580-5b34-4032-9403-c9d2154ac073">Ingredient: status = active; role = Active</a></p></blockquote><blockquote><p><b>input</b></p><p><b>type</b>: <span title="Codes:{http://who-umc.org/idmp/CodeSystem/task-input-type organization-request-resource}">Test by Datapharm for PhPID request</span></p><p><b>value</b>: <a href="#hcUK-emc-00001/dti">Organization Datapharm Test Inc</a></p></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: MedicinalProductDefinition  #5d02cfc1-053f-4694-9ce8-d0ee6c658b72</b></p><a name="UK-emc-00001/5d02cfc1-053f-4694-9ce8-d0ee6c658b72"> </a><a name="hcUK-emc-00001/5d02cfc1-053f-4694-9ce8-d0ee6c658b72"> </a><a name="UK-emc-00001/5d02cfc1-053f-4694-9ce8-d0ee6c658b72-en-US"> </a><p><b>identifier</b>: <code>http://medicines.org.uk/product</code>/511</p><p><b>type</b>: <span title="Codes:{http://hl7.org/fhir/medicinal-product-type MedicinalProduct}">Medicinal Product</span></p><p><b>domain</b>: <span title="Codes:{http://hl7.org/fhir/medicinal-product-domain Human}">Human use</span></p><p><b>status</b>: <span title="Codes:{http://hl7.org/fhir/publication-status active}">Active</span></p><p><b>statusDate</b>: 2020-08-03 15:11:41+0000</p><p><b>combinedPharmaceuticalDoseForm</b>: <span title="Codes:{http://hl7.org/fhir/combined-dose-form 100000074064}">Tablet and powder for oral solution</span></p><p><b>classification</b>: <span title="Codes:{http://www.whocc.no/atc L04AX03}">methotrexate</span></p><p><b>attachedDocument</b>: SPC/511</p><h3>Contacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Contact</b></td></tr><tr><td style="display: none">*</td><td><a href="#hcUK-emc-00001/dti">Organization Datapharm Test Inc</a></td></tr></table><blockquote><p><b>name</b></p><p><b>productName</b>: Methotrexate 2.5 mg Tablets</p><p><b>type</b>: <span title="Codes:">RegulatorApprovedName</span></p><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{urn:iso:std:iso:3166 GBR}">United Kingdom</span></td><td><span title="Codes:{urn:iso:std:iso:3166 GBR}">United Kingdom</span></td><td><span title="Codes:{urn:ietf:bcp:47 en}">English</span></td></tr></table></blockquote></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Ingredient  #54c6c580-5b34-4032-9403-c9d2154ac073</b></p><a name="UK-emc-00001/54c6c580-5b34-4032-9403-c9d2154ac073"> </a><a name="hcUK-emc-00001/54c6c580-5b34-4032-9403-c9d2154ac073"> </a><a name="UK-emc-00001/54c6c580-5b34-4032-9403-c9d2154ac073-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: <a href="#hcUK-emc-00001/5d02cfc1-053f-4694-9ce8-d0ee6c658b72">MedicinalProductDefinition: identifier = http://medicines.org.uk/product#511; type = Medicinal Product; domain = Human use; status = Active; statusDate = 2020-08-03 15:11:41+0000; combinedPharmaceuticalDoseForm = Tablet and powder for oral solution; classification = methotrexate</a></p><p><b>role</b>: <span title="Codes:{http://hl7.org/fhir/ingredient-role 100000072072}">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://who-umc.org/idmp/gsid GSID23G92UMX93H45}">Methotrexate sodium</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Presentation[x]</b></td><td><b>TextPresentation</b></td></tr><tr><td style="display: none">*</td><td>2.5 milligram<span style="background: LightGoldenRodYellow"> (Details: UCUM  codemg = 'mg')</span>/1 IU<span style="background: LightGoldenRodYellow"> (Details: Strength units applicable in the IDMP PhPID service  codeIU = 'arbitrary international unit')</span></td><td>2.5 mg</td></tr></table></blockquote></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization  #dti</b></p><a name="UK-emc-00001/dti"> </a><a name="hcUK-emc-00001/dti"> </a><a name="UK-emc-00001/dti-en-US"> </a><p><b>active</b>: true</p><p><b>type</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/organization-type bus}">Datapharm Test FCAT35</span></p><p><b>name</b>: Datapharm Test Inc</p></blockquote></div>
  </text>
  <contained>
    <MedicinalProductDefinition>
      <id value="5d02cfc1-053f-4694-9ce8-d0ee6c658b72"/>
      <meta>
        <profile
                 value="http://who-umc.org/idmp/StructureDefinition/MedicinalProductDefinition-who-php-req"/>
      </meta>
      <identifier>
        <system value="http://medicines.org.uk/product"/>
        <value value="511"/>
      </identifier>
      <type>
        <coding>
          <system value="http://hl7.org/fhir/medicinal-product-type"/>
          <code value="MedicinalProduct"/>
        </coding>
      </type>
      <domain>
        <coding>
          <system value="http://hl7.org/fhir/medicinal-product-domain"/>
          <code value="Human"/>
        </coding>
        <text value="Human use"/>
      </domain>
      <status>
        <coding>
          <system value="http://hl7.org/fhir/publication-status"/>
          <code value="active"/>
        </coding>
        <text value="Active"/>
      </status>
      <statusDate value="2020-08-03T15:11:41Z"/>
      <combinedPharmaceuticalDoseForm>
        <coding>
          <system value="http://hl7.org/fhir/combined-dose-form"/>
          <code value="100000074064"/>
          <display value="Tablet and powder for oral solution"/>
        </coding>
        <text value="Tablet and powder for oral solution"/>
      </combinedPharmaceuticalDoseForm>
      <classification>
        <coding>
          <system value="http://www.whocc.no/atc"/>
          <code value="L04AX03"/>
        </coding>
      </classification>
      <attachedDocument>
        <display value="SPC/511"/>
      </attachedDocument>
      <contact>
        <contact>
          <reference value="#dti"/>
        </contact>
      </contact>
      <name>
        <productName value="Methotrexate 2.5 mg Tablets"/>
        <type>
          <coding>
            <code value="RegulatorApprovedName"/>
          </coding>
        </type>
        <usage>
          <country>
            <coding>
              <system value="urn:iso:std:iso:3166"/>
              <code value="GBR"/>
            </coding>
          </country>
          <jurisdiction>
            <coding>
              <system value="urn:iso:std:iso:3166"/>
              <code value="GBR"/>
            </coding>
          </jurisdiction>
          <language>
            <coding>
              <system value="urn:ietf:bcp:47"/>
              <code value="en"/>
            </coding>
          </language>
        </usage>
      </name>
    </MedicinalProductDefinition>
  </contained>
  <contained>
    <Ingredient>
      <id value="54c6c580-5b34-4032-9403-c9d2154ac073"/>
      <meta>
        <profile
                 value="http://who-umc.org/idmp/StructureDefinition/Ingredient-who-php"/>
      </meta>
      <status value="active"/>
      <for>
        <reference value="#5d02cfc1-053f-4694-9ce8-d0ee6c658b72"/>
      </for>
      <role>
        <coding>
          <system value="http://hl7.org/fhir/ingredient-role"/>
          <code value="100000072072"/>
        </coding>
        <text value="Active"/>
      </role>
      <substance>
        <code>
          <concept>
            <coding>
              <system value="http://who-umc.org/idmp/gsid"/>
              <code value="GSID23G92UMX93H45"/>
            </coding>
            <text value="Methotrexate sodium"/>
          </concept>
        </code>
        <strength>
          <presentationRatio>
            <numerator>
              <value value="2.5"/>
              <unit value="milligram"/>
              <system value="http://unitsofmeasure.org"/>
              <code value="mg"/>
            </numerator>
            <denominator>
              <value value="1"/>
              <unit value="IU"/>
              <system
                      value="http://who-umc.org/idmp/CodeSystem/strengthUnit"/>
              <code value="IU"/>
            </denominator>
          </presentationRatio>
          <textPresentation value="2.5 mg"/>
        </strength>
      </substance>
    </Ingredient>
  </contained>
  <contained>
    <Organization>
      <id value="dti"/>
      <active value="true"/>
      <type>
        <coding>
          <system
                  value="http://terminology.hl7.org/CodeSystem/organization-type"/>
          <code value="bus"/>
        </coding>
        <text value="Datapharm Test FCAT35"/>
      </type>
      <name value="Datapharm Test Inc"/>
    </Organization>
  </contained>
  <status value="draft"/>
  <intent value="proposal"/>
  <priority value="routine"/>
  <authoredOn value="2024-01-17"/>
  <lastModified value="2024-01-17"/>
  <input>
    <type>
      <coding>
        <system value="http://who-umc.org/idmp/CodeSystem/task-input-type"/>
        <code value="mpd-request-resource"/>
        <display value="Medicinal Product for PhPID request"/>
      </coding>
      <text value="Medicinal Product for PhPID request"/>
    </type>
    <valueReference>
      <reference value="#5d02cfc1-053f-4694-9ce8-d0ee6c658b72"/>
    </valueReference>
  </input>
  <input>
    <type>
      <coding>
        <system value="http://who-umc.org/idmp/CodeSystem/task-input-type"/>
        <code value="ingredient-request-resource"/>
        <display value="Ingredient for PhPID request"/>
      </coding>
      <text value="Ingredient for PhPID request"/>
    </type>
    <valueReference>
      <reference value="#54c6c580-5b34-4032-9403-c9d2154ac073"/>
    </valueReference>
  </input>
  <input>
    <type>
      <coding>
        <system value="http://who-umc.org/idmp/CodeSystem/task-input-type"/>
        <code value="organization-request-resource"/>
        <display value="Marketing Auth Holder for PhPID request"/>
      </coding>
      <text value="Test by Datapharm for PhPID request"/>
    </type>
    <valueReference>
      <reference value="#dti"/>
    </valueReference>
  </input>
</Task>